NCT06422273View on ClinicalTrials.gov

Protest Trial: TXA vs Saline

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Lung TransplantComplications Surgical
Interventions
DRUG

Tranexamic Acid

Endobronchial (topical) tranexamic acid used prophylactically prior to performing transbronchial biopsies in lung transplant recipients

OTHER

Saline (placebo)

Topical Saline (placebo) administered as endobronchial topical application prior to performing transbronchial biopsies in lung transplant recipients.

Trial Locations (1)

49503

Spectrum Health Hospitals, Grand Rapids

All Listed Sponsors
lead

Spectrum Health Hospitals

OTHER